Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
The pharmacokinetics of imipenem, a new carbapenem antibiotic, and cilastatin, a metabolic inhibitor, were evaluated in 17 patients with cystic fibrosis. Imipenem and cilastatin were combined in a ratio of 1:1 in the infusion solution, and patients intravenously received 30, 60, or 90 mg of imipenem...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1985
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180100/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3859245/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.583 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|